Incorporating the above three factors into the multivariate analysis, the results suggested that high expression of RAD21, advanced stage, and lymph node metastasis were independent risk factors affecting the survival and prognosis of patients with epithelial ovarian cancer (Figure 1E). The gene discussed is RAD21; the disease is metastatic malignant neoplasm in the lymph nodes.